182 related articles for article (PubMed ID: 11706089)
1. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies.
Giraud M; Beaurain G; Yamamoto AM; Eymard B; Tranchant C; Gajdos P; Garchon HJ
Neurology; 2001 Nov; 57(9):1555-60. PubMed ID: 11706089
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.
Vandiedonck C; Beaurain G; Giraud M; Hue-Beauvais C; Eymard B; Tranchant C; Gajdos P; Dausset J; Garchon HJ
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15464-9. PubMed ID: 15489265
[TBL] [Abstract][Full Text] [Related]
4. Anti-titin antibodies are not associated with a specific thymoma histology.
Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
[No Abstract] [Full Text] [Related]
5. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
[No Abstract] [Full Text] [Related]
6. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
[TBL] [Abstract][Full Text] [Related]
8. Sera from myasthenia gravis patients recognize the PEVK domain of titin.
Mihovilovic M; Mai Y; Austin C; Roses AD
Ann N Y Acad Sci; 1998 May; 841():534-7. PubMed ID: 9668289
[No Abstract] [Full Text] [Related]
9. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations.
Skeie GO; Mygland A; Aarli JA; Gilhus NE
Autoimmunity; 1995; 20(2):99-104. PubMed ID: 7578874
[TBL] [Abstract][Full Text] [Related]
10. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
12. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
Huang DR; Pirskanen R; Matell G; Lefvert AK
J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
[TBL] [Abstract][Full Text] [Related]
14. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.
Greve B; Hoffmann P; Illes Z; Rozsa C; Berger K; Weissert R; Melms A
Hum Immunol; 2009 Jul; 70(7):540-2. PubMed ID: 19406179
[TBL] [Abstract][Full Text] [Related]
15. Antibodies in sera of patients with late-onset myasthenia gravis recognize the PEVK domain of titin.
Mihovilovic M; Ciafaloni E; Butterworth-Robinette J; Jin JP; Massey J; Sanders DB
Ann N Y Acad Sci; 2003 Sep; 998():351-5. PubMed ID: 14592895
[No Abstract] [Full Text] [Related]
16. Tumour necrosis factor beta gene polymorphisms in myasthenia gravis.
Zelano G; Lino MM; Evoli A; Settesoldi D; Batocchi AP; Torrente I; Tonali PA
Eur J Immunogenet; 1998 Dec; 25(6):403-8. PubMed ID: 9949945
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune human T lymphocytes specific for acetylcholine receptor.
Hohlfeld R; Toyka KV; Heininger K; Grosse-Wilde H; Kalies I
Nature; 1984 Jul 19-25; 310(5974):244-6. PubMed ID: 6611507
[TBL] [Abstract][Full Text] [Related]
18. [Antigens of histocompatibility in children with myasthenia gravis].
Neretin VIa; Serova LD; Agafonov BV; Tsuman VG; Gekht BM; Sidorova OP; Nalivkin AE
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):44-8. PubMed ID: 11523395
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors in myasthenia gravis: a family study.
Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
[TBL] [Abstract][Full Text] [Related]
20. Refractory myasthenia gravis: Characteristics of a portuguese cohort.
Santos E; Bettencourt A; Duarte S; Gabriel D; Oliveira V; da Silva AM; Costa PP; Lopes C; Gonçalves G; da Silva BM; Leite MI
Muscle Nerve; 2019 Aug; 60(2):188-191. PubMed ID: 31050006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
